← Back to Search

Smoking Cessation Interventions for Quitting Smoking

N/A

Recruiting

Led By Steven Fu, MD, MSCE

Research Sponsored by University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6, 12, and 18 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will test an approach to help BIPOC smokers access evidence-based, culturally tailored tobacco cessation treatments.

Who is the study for?

This trial is for BIPOC individuals who are part of the Hennepin Healthcare or MCHS system, speak English or Spanish, currently smoke cigarettes, and want to quit. They must have contact information in their health record. People with cognitive impairments or under legal guardianship, or those who've opted out of research can't participate.

What is being tested?

The study tests two methods to help BIPOC smokers quit: Ask-Advice-Connect (AAC) and Longitudinal Proactive Outreach (LPO). It aims to see if proactive outreach using these methods increases the use of evidence-based cessation treatments compared to standard care.

What are the potential side effects?

Since this trial focuses on smoking cessation approaches rather than medications, it may not have typical side effects. Participants might experience stress or discomfort related to quitting smoking.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6, 12, and 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6, 12, and 18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6, 12, and 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

7-day point-prevalence smoking abstinence at 18 months

Secondary study objectives

Change in Overall Quality of Life

Change in Theory of Planned Behavior Questionnaire (TPB-Q) Score

Change in Treatment utilization.

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: AAC + Longitudinal Proactive Outreach (LPO)Experimental Treatment2 Interventions

AAC+LPO participants will receive AAC plus an MI tailored outreach call at baseline and at 3, 6, and 9 months post-enrollment. AAC includes enhanced access to State Quitline and Nicotine Replacement Therapy.

Group II: Enhanced Usual Care: Ask-Advice-Connect (AAC)Active Control1 Intervention

AAC participants will receive care through their primary care provider as usual (with the caveat that providers in the clinics will be trained to provide AAC). AAC includes enhanced access to State Quitline and Nicotine Replacement Therapy.

Do I qualify?Apply below to find out